AstraZeneca Hits Record High, Becomes UK’s Most Valuable Stock
Source: www.reuters.com Key Points: AstraZeneca shares hit a record £134.6, making it the UK’s most valuable stock. Strong earnings and a U.S. drug pricing deal boosted investor confidence. The rise helped push the FTSE 100 to record highs and highlights the healthcare sector’s strength. AstraZeneca shares climbed to an all-time high on Tuesday, solidifying the pharmaceutical company’s position as the most valuable stock on the London Stock Exchange. The gain followed strong quarterly results and a U.S. policy deal that eased investor concerns about drug pricing. Shares reach new milestone By 8:32 a.m. GMT, AstraZeneca shares rose 2.5% to 134.6 pounds, surpassing their September 2024 peak. The rally lifted the company’s market capitalization to nearly 210 billion pounds ($282 billion). The broader FTSE 100 index also gained 1.1%, reaching a record high amid optimism over possible interest rate cuts by the Bank of England next month. The increase continues a positive trend for AstraZene...